VESCOVI ANGELO LUIGI

Ruotolo, G., D'Anzi, A., Casamassa, A., Mazzoni, M., Ferrari, D., Lombardi, I., et al. (2024). Generation of induced pluripotent stem cells (CSSi017-A)(12862) from an ALS patient carrying a repeat expansion in the C9orf72 gene. STEM CELL RESEARCH, 77(June 2024) [10.1016/j.scr.2024.103412]. Detail

Leone, M., Gelati, M., Profico, D., Gobbi, C., Pravata, E., Copetti, M., et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. CELL STEM CELL, 30(12), 1597-1609 [10.1016/j.stem.2023.11.001]. Detail

Rotundo, G., Turco, E., Ruotolo, G., Torrente, I., Candido, O., Lopez, G., et al. (2023). Generation of an induced pluripotent stem cell line CSSi015-A (9553), carrying a point mutation c.2915C > T in the human calcium sensing receptor (CasR) gene. STEM CELL RESEARCH, 67(March 2023), 1-5 [10.1016/j.scr.2023.103023]. Detail

Ferrari, D., D'Anzi, A., Casamassa, A., Bernardini, L., Tata, A., Vescovi, A., et al. (2022). Functional outcomes of copy number variations of Chrna7 gene: Current knowledge and new insight from induced pluripotent stem cells studies. In A. Birbrair (a cura di), Novel Concepts in iPSC Disease Modeling (pp. 269-306). Academic Press [10.1016/B978-0-12-823882-0.00012-6]. Detail

Profico, D., Gelati, M., Ferrari, D., Sgaravizzi, G., Ricciolini, C., Projetti Pensi, M., et al. (2022). Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(21) [10.3390/ijms232113425]. Detail